| ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab (NCT05366062) | Epitopoietic Research Corporation | 2022-07-01 |
| Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas (NCT05393258) | Washington University School of Medicine | 2022-06-28 |
| Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma (NCT05226494) | NanoPharmaceuticals LLC | 2022-06-23 |
| AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients (NCT05182905) | Nader Sanai | 2022-05-27 |
| Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem (NCT05556486) | Karolinska University Hospital | 2022-05-05 |
| Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM (NCT05271240) | Northwell Health | 2022-04-27 |
| An Integrated Radio-immunological Approach (NCT05267509) | Istituto Oncologico Veneto IRCCS | 2022-02-23 |
| 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas (NCT06499831) | Sunnybrook Health Sciences Centre | 2021-12-15 |
| Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging (NCT05656053) | Mingge LLC | 2021-11-15 |
| Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma (NCT05076513) | Nader Sanai | 2021-10-29 |
| Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients (NCT04998864) | InSightec | 2021-08-25 |
| Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban (NCT04895553) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-01 |
| Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection (NCT04904419) | Jinsong Wu | 2021-08-01 |
| Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma (NCT04547777) | Darell Bigner | 2021-07-09 |
| Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection (NCT04608812) | OncoSynergy, Inc. | 2021-03-02 |
| Modulation of Ciliogenesis in Glioma Stem Cells (NCT05772767) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-02-15 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| Effect of Perampanel on Peritumoral Hyperexcitability in HGG (NCT04497142) | Dana-Farber Cancer Institute | 2020-11-05 |
| Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome (NCT04562077) | Assiut University | 2020-10-01 |
| HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM (NCT04547621) | Huashan Hospital | 2020-09-01 |
| Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin (NCT05896449) | Medical University of Warsaw | 2020-06-01 |
| The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients (NCT05063682) | Chembrain LTD | 2020-05-15 |
| Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) (NCT04222309) | Northwell Health | 2020-01-06 |
| Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma (NCT04091503) | Center Trials & Treatment Europe | 2019-12-20 |
| Molecular Pathology Research Project of Glioma (NCT04924127) | Jinsong Wu | 2019-12-05 |
| Glioma: Biomolecular Aspects (NCT05806619) | Regina Elena Cancer Institute | 2019-10-22 |
| Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas (NCT05969691) | Mingge LLC | 2019-03-15 |
| Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs (NCT05772741) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2018-12-03 |
| Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery (NCT05873946) | Hospital del Rio Hortega | 2018-06-01 |
| Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) (NCT03392545) | Beijing Tiantan Hospital | 2018-04-01 |
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
| GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas (NCT03576612) | Candel Therapeutics, Inc. | 2018-02-27 |
| ONC201 in Pediatric H3 K27M Gliomas (NCT03416530) | Jazz Pharmaceuticals | 2018-01-25 |
| Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients (NCT05100602) | Genetron Health | 2016-05-13 |
| Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients (NCT05100173) | Genetron Health | 2016-05-13 |
| Glioblastoma and Individualized Therapies (NCT05356312) | Zentrum fur Humangenetik Tuebingen | |